1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Anti-Radiation Drugs Market
2.2. Global Anti-Radiation Drugs Market, By Compound, 2023 (US$ Million)
2.3. Global Anti-Radiation Drugs Market, By Application, 2023 (US$ Million)
2.4. Global Anti-Radiation Drugs Market, By Distribution Channel, 2023 (US$ Million)
2.5. Global Anti-Radiation Drugs Market, By Geography, 2023 (US$ Million)
2.6. Attractive Investment Proposition by Geography, 2023

3. Anti-Radiation Drugs Market: Competitive Analysis
3.1. Market Positioning of Key Anti-Radiation Drugs Market Vendors
3.2. Strategies Adopted by Anti-Radiation Drugs Market Vendors
3.3. Key Industry Strategies
4. Anti-Radiation Drugs Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Anti-Radiation Drugs Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Potassium Iodide (KI)
5.3.2. Prussian Blue
5.3.3. DTPA (Diethylenetriamine Pentaacetate)
5.3.4. Others

6. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Acute Radiation Syndrome (ARS)
6.3.2. Cancer Treatment
6.3.3. Radiation Exposure
6.3.4. Others

7. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2023 Versus 2032
7.3. Market Segmentation
7.3.1. Hospital Pharmacies
7.3.2. Retail Pharmacies
7.3.3. Others


8. North America Anti-Radiation Drugs Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
8.3. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
8.4. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
8.5.Anti-Radiation Drugs Market: By Region, 2022-2032, USD (Million)
8.5.1.North America
8.5.1.1. U.S.
8.5.1.1.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
8.5.1.1.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
8.5.1.1.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
8.5.1.2. Canada
8.5.1.2.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
8.5.1.2.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
8.5.1.2.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
8.5.1.3. Rest of North America
8.5.1.3.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
8.5.1.3.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
8.5.1.3.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)

9. UK and European Union Anti-Radiation Drugs Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
9.3. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
9.4. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
9.5.Anti-Radiation Drugs Market: By Region, 2022-2032, USD (Million)
9.5.1.UK and European Union
9.5.1.1. UK
9.5.1.1.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
9.5.1.1.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
9.5.1.1.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
9.5.1.2. Germany
9.5.1.2.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
9.5.1.2.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
9.5.1.2.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
9.5.1.3. Spain
9.5.1.3.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
9.5.1.3.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
9.5.1.3.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
9.5.1.4. Italy
9.5.1.4.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
9.5.1.4.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
9.5.1.4.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
9.5.1.5. France
9.5.1.5.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
9.5.1.5.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
9.5.1.5.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
9.5.1.6. Rest of Europe
9.5.1.6.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
9.5.1.6.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
9.5.1.6.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)

10. Asia Pacific Anti-Radiation Drugs Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
10.3. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
10.4. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
10.5.Anti-Radiation Drugs Market: By Region, 2022-2032, USD (Million)
10.5.1.Asia Pacific
10.5.1.1. China
10.5.1.1.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
10.5.1.1.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
10.5.1.1.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
10.5.1.2. Japan
10.5.1.2.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
10.5.1.2.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
10.5.1.2.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
10.5.1.3. India
10.5.1.3.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
10.5.1.3.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
10.5.1.3.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
10.5.1.4. Australia
10.5.1.4.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
10.5.1.4.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
10.5.1.4.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
10.5.1.5. South Korea
10.5.1.5.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
10.5.1.5.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
10.5.1.5.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
10.5.1.6. Rest of Asia Pacific
10.5.1.6.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
10.5.1.6.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
10.5.1.6.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)

11. Latin America Anti-Radiation Drugs Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
11.3. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
11.4. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
11.5.Anti-Radiation Drugs Market: By Region, 2022-2032, USD (Million)
11.5.1.Latin America
11.5.1.1. Brazil
11.5.1.1.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
11.5.1.1.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
11.5.1.1.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
11.5.1.2. Mexico
11.5.1.2.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
11.5.1.2.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
11.5.1.2.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
11.5.1.3. Rest of Latin America
11.5.1.3.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
11.5.1.3.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
11.5.1.3.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)

12. Middle East and Africa Anti-Radiation Drugs Market, 2022-2032, USD (Million)
12.1. Market Overview
12.2. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
12.3. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
12.4. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
12.5.Anti-Radiation Drugs Market: By Region, 2022-2032, USD (Million)
12.5.1.Middle East and Africa
12.5.1.1. GCC
12.5.1.1.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
12.5.1.1.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
12.5.1.1.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
12.5.1.2. Africa
12.5.1.2.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
12.5.1.2.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
12.5.1.2.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
12.5.1.3. Rest of Middle East and Africa
12.5.1.3.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
12.5.1.3.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
12.5.1.3.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)

13. Company Profile
13.1. Recipharm AB
13.1.1. Company Overview
13.1.2. Financial Performance
13.1.3. Product Portfolio
13.1.4. Strategic Initiatives
13.2. NukeRx
13.2.1. Company Overview
13.2.2. Financial Performance
13.2.3. Product Portfolio
13.2.4. Strategic Initiatives
13.3. Bausch Health Companies Inc
13.3.1. Company Overview
13.3.2. Financial Performance
13.3.3. Product Portfolio
13.3.4. Strategic Initiatives
13.4. Amgen Inc.
13.4.1. Company Overview
13.4.2. Financial Performance
13.4.3. Product Portfolio
13.4.4. Strategic Initiatives
13.5. Anbex Inc.
13.5.1. Company Overview
13.5.2. Financial Performance
13.5.3. Product Portfolio
13.5.4. Strategic Initiatives
13.6. Arco Pharmaceuticals LLC
13.6.1. Company Overview
13.6.2. Financial Performance
13.6.3. Product Portfolio
13.6.4. Strategic Initiatives
13.7. BTG International Inc.
13.7.1. Company Overview
13.7.2. Financial Performance
13.7.3. Product Portfolio
13.7.4. Strategic Initiatives
13.8. Cellphire, Inc.
13.8.1. Company Overview
13.8.2. Financial Performance
13.8.3. Product Portfolio
13.8.4. Strategic Initiatives
13.9. Chrysalis BioTherapeutics, Inc.
13.9.1. Company Overview
13.9.2. Financial Performance
13.9.3. Product Portfolio
13.9.4. Strategic Initiatives
13.10. Darnitsa
13.10.1. Company Overview
13.10.2. Financial Performance
13.10.3. Product Portfolio
13.10.4. Strategic Initiatives
13.11. Enzychem Lifesciences Corporation
13.11.1. Company Overview
13.11.2. Financial Performance
13.11.3. Product Portfolio
13.11.4. Strategic Initiatives
13.12. Humanetics Corporation
13.12.1. Company Overview
13.12.2. Financial Performance
13.12.3. Product Portfolio
13.12.4. Strategic Initiatives
13.13. Mission Pharmacal Company
13.13.1. Company Overview
13.13.2. Financial Performance
13.13.3. Product Portfolio
13.13.4. Strategic Initiatives
13.14. Myelo Therapeutics GmbH
13.14.1. Company Overview
13.14.2. Financial Performance
13.14.3. Product Portfolio
13.14.4. Strategic Initiatives
13.15. Partner Therapeutics
13.15.1. Company Overview
13.15.2. Financial Performance
13.15.3. Product Portfolio
13.15.4. Strategic Initiatives
13.16. Pluri Inc.
13.16.1. Company Overview
13.16.2. Financial Performance
13.16.3. Product Portfolio
13.16.4. Strategic Initiatives
13.17. Other Notable Players
13.17.1. Company Overview
13.17.2. Financial Performance
13.17.3. Product Portfolio
13.17.4. Strategic Initiatives